BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180821
DTEND;VALUE=DATE:20180923
DTSTAMP:20260730T054610
CREATED:20180821T064631Z
LAST-MODIFIED:20180821T064631Z
UID:20508-1534809600-1537660799@ces.b2sg.org
SUMMARY:Senior Scientist - Discovery Oncology
DESCRIPTION:We are seeking a highly qualified scientist with a strong background in oncology to join our Discovery Oncology team in Boston. The successful candidate will have a track record of innovative and collaborative research\, demonstrated through peer-reviewed publications. Primary responsibilities will include designing and carrying out experiments in the lab to build and support projects in the early discovery pipeline. An ability to communicate clearly and collaborate effectively with colleagues in the discovery group as well as scientists from different disciplines will be essential.\nThe specific responsibilities of the candidate include but are not limited to:\n\n\nDesign\, conduct\, interpret and report in vitro and cellular oncology studies using a wide range of established methodologies.\nDevelop new methods and protocols where needed.\nEnsure data generated is communicated in a concise\, easy to understand manner to the appropriate teams and stakeholders.\nMonitor\, review and critically interpret published work to guide internal research\nContribute scientifically to oncology drug discovery research programs\, including identification and validation of novel targets.\nCollaborate with members from other functional areas\, including medicinal chemistry\, in vivo and in vitro pharmacology and translational sciences.\nWork with external academic\, biotechnology\, and contract research organizations.\n\n\nQualifications \nEducation Minimum Requirement: PhD in an area relevant to oncology\nRequired Experience and Skills:\n\nA minimum of 1 year of post-doctoral experience in oncology.\nDeep technical and practical experience in cellular models and pathways of cancer.\nCandidate should be a strong team player with excellent oral and written communication skills and with a demonstrated ability to work independently to design experiments\, interpret data\, troubleshoot\, and suggest next steps.\n\n\nPreferred Experience and Skills:\n\nKnowledge of epigenetics\, DNA damage repair and/or immuno-oncology.\nProven record of innovative thinking to propose and champion new ideas and solve problems.\nDemonstrated ability to thrive in a team environment.\nPrior drug discovery experience.\n\n\nYour role at Merck is integral to helping the world meet new breakthroughs that affect generations to come\, and we’re counting on your skills and inventiveness to help make meaningful contributions to global medical advancement. At Merck\, we’re inventing for life.\nIf you need assistance and/or a reasonable accommodation due to a disability during the application or the recruiting process\, please send a request to staffingaadar@merck.com.
URL:https://ces.b2sg.org/event/merck-21aug18/
LOCATION:Merck\, 33 Avenue Louis Pasteur\, Boston\, MA\, 02115\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/09/merck.jpg
END:VEVENT
END:VCALENDAR